• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Lazard Appoints Peter Harrison to Board of Directors

    3/3/25 8:00:00 AM ET
    $LAZ
    Investment Managers
    Finance
    Get the next $LAZ alert in real time by email

    Board Leadership Reinforces Lazard's Asset Management Strategy

    Lazard, Inc. (NYSE:LAZ) today announced that Peter Harrison has been appointed to its Board of Directors, effective today. Mr. Harrison has more than 35 years of experience in investment management, most recently serving as Group CEO of Schroders plc, a global investment manager and FTSE 100 company, from 2016 until his retirement in 2024. This appointment reinforces Lazard's focus on further strengthening and diversifying its asset management business.

    "We are excited to welcome Peter to our Board of Directors, where his experience is particularly valuable as we further strengthen our asset management business," said Peter R. Orszag, CEO and Chairman of the Board. "Peter exemplifies the world-class leadership we attract to Lazard, and his network of relationships in the U.K. and globally will help us advance our long-term growth strategy."

    "I am honored to join Lazard's Board of Directors and help advise the company on its growth ambitions. Lazard is a renowned firm that is clearly at an inflection point as it continues to evolve to meet client needs. I look forward to contributing to this evolution and helping to realize the vision for Lazard's future," said Mr. Harrison.

    Mr. Harrison is an accomplished global executive. As Group CEO of Schroders, the firm's assets under management more than doubled to over £750 billion under his leadership, reflecting an evolution of the business into private markets and wealth management that included a transformative joint venture with Lloyds Banking Group. His prior experience also includes senior roles at J.P. Morgan and Deutsche Asset Management, and CEO and later Chairman of RWC Partners Limited. Mr. Harrison has served as a founding member of the UK Treasury's Asset Management Taskforce and the Capital Markets Industry Taskforce, and he is Chair of Business in the Community, the King's responsible business charity.

    "Peter is an excellent addition to our Board, bringing extensive experience in asset management that will complement our current leadership and oversight," said Dan Schulman, Lead Independent Director of Lazard's Board. "Following the expansion of our Board last year, Peter's appointment demonstrates our ongoing investment in building for Lazard's future."

    About Lazard

    Founded in 1848, Lazard is one of the world's preeminent financial advisory and asset management firms, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit www.lazard.com.

    LAZ-CPE

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250303778851/en/

    Media Relations

    Aziz Nayani

    +1 212-632-6042

    [email protected]

    Investor Relations

    Alexandra Deignan

    +1 212-632-6886

    [email protected]

    Get the next $LAZ alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAZ

    DatePrice TargetRatingAnalyst
    8/25/2025$65.00Mkt Perform → Outperform
    Keefe Bruyette
    4/7/2025$56.00 → $33.00Equal-Weight → Underweight
    Morgan Stanley
    1/3/2025Outperform → Peer Perform
    Wolfe Research
    12/20/2024$65.00 → $57.00Outperform → Mkt Perform
    Keefe Bruyette
    12/9/2024$60.00 → $63.00Overweight → Equal-Weight
    Morgan Stanley
    9/12/2024$51.00Equal Weight
    Wells Fargo
    1/29/2024$51.00Outperform
    Keefe Bruyette
    1/3/2024$42.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $LAZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lazard upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Lazard from Mkt Perform to Outperform and set a new price target of $65.00

    8/25/25 8:08:17 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Lazard from Equal-Weight to Underweight and set a new price target of $33.00 from $56.00 previously

    4/7/25 7:56:16 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard downgraded by Wolfe Research

    Wolfe Research downgraded Lazard from Outperform to Peer Perform

    1/3/25 7:37:05 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lazard Welcomes Cyrille Cotte as Managing Director and Head of Insurance for European Financial Institutions

    Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio

    10/1/25 2:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in August

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on October 22, 2025, to shareholders of record on October 10, 2025. The ex-dividend date is October 10, 2025. The Fund will pay a previously declared distribution today, September 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,

    9/22/25 4:05:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Hires Geoffrey Porges to Healthcare Advisory Group

    Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an

    9/18/25 7:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    SEC Filings

    View All

    SEC Form 144 filed by Lazard Inc.

    144 - Lazard, Inc. (0001311370) (Subject)

    9/10/25 4:41:06 PM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Lazard, Inc. (0001311370) (Filer)

    9/10/25 8:00:24 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Lazard, Inc. (0001311370) (Filer)

    9/8/25 8:01:09 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Shevelenko Dmitry

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/18/25 4:30:18 PM ET
    $LAZ
    Investment Managers
    Finance

    CEO & Chairman Orszag Peter Richard converted options into 64,949 shares, returned $1,083,171 worth of shares to the company (19,485 units at $55.59) and sold $1,756,573 worth of shares (32,475 units at $54.09), increasing direct ownership by 8% to 183,274 units (SEC Form 4)

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/17/25 8:06:50 PM ET
    $LAZ
    Investment Managers
    Finance

    CEO of Asset Management Russo Evan L gifted 15,000 shares and sold $4,240,260 worth of shares (75,000 units at $56.54), decreasing direct ownership by 28% to 227,915 units (SEC Form 4)

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/11/25 7:27:29 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Financials

    Live finance-specific insights

    View All

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in August

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on October 22, 2025, to shareholders of record on October 10, 2025. The ex-dividend date is October 10, 2025. The Fund will pay a previously declared distribution today, September 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,

    9/22/25 4:05:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in July

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on September 22, 2025, to shareholders of record on September 11, 2025. The ex-dividend date is September 11, 2025. The Fund will pay a previously declared distribution today, August 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment incom

    8/22/25 4:05:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Reports Second Quarter and First Half 2025 Results

    Financial Advisory reported record adjusted net revenue for the second quarter up 20% year over year and driven by robust activity in Europe Asset Management reported positive net flows in the second quarter and AUM of $248 billion as of June 30, 2025 Financial Advisory hired 14 Managing Directors year to date, underscoring success in attracting world-class talent to support long-term growth Lazard, Inc. (NYSE:LAZ) today reported net revenue of $796 million and adjusted net revenue1 of $770 million for the quarter ended June 30, 2025. For the first half of 2025, Lazard reported net revenue of $1,444 million and adjusted net revenue1 of $1,413 million. On both a U.S. GAAP and

    7/24/25 6:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Leadership Updates

    Live Leadership Updates

    View All

    Lazard Welcomes Cyrille Cotte as Managing Director and Head of Insurance for European Financial Institutions

    Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio

    10/1/25 2:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Hires Geoffrey Porges to Healthcare Advisory Group

    Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an

    9/18/25 7:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Christopher Hogbin Joins Lazard Asset Management as Chief Executive Officer

    Succeeds Evan Russo who transitions into advisory role following two decades of leadership at the firm Lazard, Inc. (NYSE:LAZ) today announced Christopher Hogbin has been appointed CEO of Lazard Asset Management, effective December 2025. Mr. Hogbin has 30 years of professional experience, including 20 years at AllianceBernstein where he most recently served as Global Head of Investments and a member of its Executive Leadership Team. An accomplished global business and investment leader, Mr. Hogbin played a pivotal role in expanding and diversifying AllianceBernstein's investment capabilities across public and private markets, elevating its research function, and delivering exceptional out

    9/8/25 8:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Lazard Inc.

    SC 13G - Lazard, Inc. (0001311370) (Subject)

    11/8/24 2:17:07 PM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/14/24 9:41:26 AM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/9/24 9:16:05 AM ET
    $LAZ
    Investment Managers
    Finance